PDF herunterladen
Open Access
CC BY-NC-ND 4.0 · South Asian J Cancer 2025; 14(02): 197-207
DOI: 10.1055/s-0043-1771405
Original Article
Quality of Life Section

Psycho-oncology/Supportive Care in Head–Neck Cancers Patients Undergoing Radiation Therapy: A Randomized Controlled Trial

Autor*innen

  • Shwetabh Sinha

    1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Saket Pandey

    2   Department of Radiation Oncology, Apollo Hospital, Lucknow, Uttar Pradesh, India

  • Shirley L. Salins

    3   Department of Radiotherapy and Oncology, Kasturba Medical College, Manipal, Karnataka, India

  • Naveen Salins 

    4   Department of Palliative Medicine, Kasturba Medical College, Manipal, Karnataka, India

  • Jayita Deodhar

    5   Department of Palliative Medicine, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Tejpal Gupta

    1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Sarbani G. Laskar 

    1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Ashwini Budrukkar

    1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Monali Swain

    1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Anuj Kumar

    1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Vedang Murthy

    1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Sudhir Nair

    6   Department of Head and Neck Surgery, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Deepa Nair

    6   Department of Head and Neck Surgery, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Poonam Joshi

    6   Department of Head and Neck Surgery, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Pankaj Chaturvedi

    6   Department of Head and Neck Surgery, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Nandini Menon 

    7   Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Vijay Patil

    7   Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Amit Joshi

    7   Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Vanita Noronha 

    7   Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Kumar Prabhash

    7   Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

  • Jai Prakash Agarwal

    1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India

Funding The trial was funded by an intramural grant from Department of Atomic Energy of India (DAE)—Clinical Trial Centre (CTC), Tata Memorial Centre.
Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints

Abstract

An elevated level of distress is associated with poor health-related quality of life (QoL), decreased patient satisfaction, poor treatment compliance, and possible reduced survival. This randomized trial, conducted at a single center in India, enrolled head–neck cancer patients aged > 18 years who were undergoing curative intent radiation therapy, and had significant baseline distress as per the National Comprehensive Cancer Network distress thermometer (distress score ≥ 4). The patients were randomized into the Standard arm (STD), which involved routine assessment by the oncologist, or the Interventional arm (INV), where psycho-oncology/palliative/supportive care referral was done at baseline and every week during treatment. The study's primary endpoint was the proportion of patients having significant distress 6 months' posttreatment. A total of 212 patients were randomized (n = 108 STD, n = 104 INV). At 6 months' post-treatment completion, 90 and 89 were evaluable in the STD and INV, respectively. The median distress score was 2 in both arms at this time point. There was no significant difference in the proportion of patients having significant distress in STD versus INV (9 vs. 15.6%, p = 0.20). There was an improvement in any symptom measured by the Edmonton Symptom Assessment Score (pain, tiredness, drowsiness, nausea, lack of appetite) and the QoL for the entire cohort with no statistically significant difference between arms for symptoms, QoL, or survival endpoints. Psycho-oncology and palliative/supportive care referral did not impact distress, symptom burden, QoL, or survival at 6 months' posttreatment completion significantly in this randomized trial.

Clinical Trial Registry of India Registration number: CTRI/2016/01/006549.

Keywords

distress - head–neck cancer - palliative care referral - psycho-oncology referral - quality of life - supportive care

Note

The study results were presented as a proffered paper at the ESTRO 2022 conference held in Copenhagen in May 2022.




Publikationsverlauf

Artikel online veröffentlicht:
31. Juli 2023

© 2023. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India